Functional genomic methods to study estrogen receptor activity

Journal of Mammary Gland Biology and Neoplasia

Volumn 17, Issue 2, 2012, Pages 147-153

  Gilfillan, Siv ^a   Fiorito, Elisa ^a   Hurtado, Antoni ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Breast cancer; Chromatin immunoprecipitation; Estrogen receptor; FAIRE; Functional genomics; Hormone resistance; Tamoxifen

Indexed keywords

EPIDERMAL GROWTH FACTOR; ESTROGEN RECEPTOR; FULVESTRANT; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; RNA POLYMERASE II; TAMOXIFEN; TRANSCRIPTION FACTOR GATA 3;

ARTICLE; BREAST CANCER; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; DNA CROSS LINKING; DNA DETERMINATION; DNA ISOLATION; FORMALDEHYDE ASSISTED ISOLATION OF REGULATORY ELEMENT; FUNCTIONAL GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN; IN VITRO STUDY; NUCLEIC ACID ANALYSIS; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN DNA INTERACTION; PROTEIN ISOLATION; TISSUE GROWTH; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CROSS-LINKING REAGENTS; DNA-BINDING PROTEINS; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; HUMANS; LIGANDS; MAMMARY GLANDS, HUMAN; NEOPLASM PROTEINS; RECEPTORS, ESTROGEN; REGULATORY ELEMENTS, TRANSCRIPTIONAL; RESPONSE ELEMENTS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 84865748567     PISSN: 10833021     EISSN: 15737039     Source Type: Journal    
DOI: 10.1007/s10911-012-9254-4     Document Type: Article

References (24)

1. Prat A, Baselga J. The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2. Nat Clin Pract Oncol. 2008;5:531.
2. Duong V, et al. ERalpha and ERbeta expression and transcriptional activity are differentially regulated by HDAC inhibitors. Oncogene. 2006;25:1799.
3. Frasor J, et al. Profiling of estrogen up-and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology. 2003;144:4562.
4. Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat Genet. 2011;43:27.
5. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell. 2000;103:843.
6. Chang EC, Frasor J, Komm B, Katzenellenbogen BS. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology. 2006;147:4831.
7. Carroll JS, Brown M. Estrogen receptor target gene: An evolving concept. Mol Endocrinol. 2006;20:1707.
8. Narita M, et al. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell. 2006;126:503.
9. Schmidt D, et al. ChIP-seq: Using high-throughput sequencing to discover protein-DNA interactions. Methods. 2009;48:240.
10. Hurtado A, et al. Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. Nature. 2008;456:663.
11. Robinson JL, et al. Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1. EMBO J. 2012;31:1617.
12. Carroll JS, et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet. 2006;38:1289.
13. Lin CY, et al. Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet. 2007;3:e87.
14. Fullwood MJ, et al. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature. 2009;462:58.
15. Ross-Innes CS, et al. Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer. Genes Dev. 2010;24:171.
16. Kong SL, Li G, Loh SL, Sung WK, Liu ET. Cellular reprogramming by the conjoint action of ERalpha, FOXA1, and GATA3 to a ligand-inducible growth state. Mol Syst Biol. 2011;7:526.
17. Lupien M, et al. Growth factor stimulation induces a distinct ER (alpha) cistrome underlying breast cancer endocrine resistance. Genes Dev. 2010;24:2219.
18. Ross-Innes CS, et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature. 2012;481:389.
19. Welboren WJ, et al. ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J. 2009;28:1418.
20. Li H, Ruan J, Durbin R. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res. 2008;18:1851.
21. Hinrichs AS, et al. The UCSC genome browser database: Update 2006. Nucleic Acids Res. 2006;34:D590.
22. Zhang Y, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9:R137.
23. Saldanha AJ. Java Treeview-extensible visualization of microarray data. Bioinformatics. 2004;20:3246.
24. Giresi PG, Lieb JD. Isolation of active regulatory elements from eukaryotic chromatin using FAIRE (Formaldehyde Assisted Isolation of Regulatory Elements). Methods. 2009;48:233.